Suministro de Fármacos Bioequivalentes Críticos
Suministro de Fármacos Bioequivalentes Críticos
21 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058071-717-SE26 | 02-07-2026 | Laboratorios Andromaco S.A. | $76.160 |
| 1058071-669-SE26 | 20-06-2026 | Guillermo Harding y Compania Limitada | $107.100 |
| 1058071-614-SE26 | 09-06-2026 | Laboratorio Pasteur S.A. | $476.238 |
| 1058071-540-SE26 | 19-05-2026 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-483-SE26 | 05-05-2026 | Laboratorio Pasteur S.A. | $107.100 |
| 1058071-423-SE26 | 20-04-2026 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-347-SE26 | 02-04-2026 | Laboratorio Pasteur S.A. | $107.100 |
| 1058071-252-SE26 | 04-03-2026 | Laboratorios Andromaco S.A. | $624.750 |
| 1058071-211-SE26 | 24-02-2026 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-153-SE26 | 10-02-2026 | Laboratorios Andromaco S.A. | $787.185 |
| 1058071-72-SE26 | 20-01-2026 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-19-SE26 | 14-01-2026 | Ascend Laboratories SpA | $12.035.784 |
| 1058071-22-SE26 | 09-01-2026 | Laboratorios Andromaco S.A. | $787.185 |
| 1058071-2944-SE25 | 17-12-2025 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-2948-SE25 | 17-12-2025 | Novofarma Service S.A. | $603.792 |
| 1058071-2911-SE25 | 04-12-2025 | Ascend Laboratories SpA | $11.223.109 |
| 1058071-2825-SE25 | 06-11-2025 | Ascend Laboratories SpA | $16.362.500 |
| 1058071-2807-SE25 | 27-10-2025 | Novofarma Service S.A. | $862.560 |
| 1058071-2784-SE25 | 24-10-2025 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-2747-SE25 | 06-10-2025 | Ascend Laboratories SpA | $2.027.855 |
| 1058071-2698-SE25 | 29-09-2025 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-2658-SE25 | 09-09-2025 | Ascend Laboratories SpA | $2.618.319 |
| 1058071-2657-SE25 | 08-09-2025 | Novofarma Service S.A. | $603.792 |
| 1058071-2621-SE25 | 02-09-2025 | Ascend Laboratories SpA | $2.027.855 |
| 1058071-2477-SE25 | 14-08-2025 | Guillermo Harding y Compania Limitada | $214.200 |
| 1058071-2543-SE25 | 11-08-2025 | Ascend Laboratories SpA | $8.001.065 |
| 1058071-2484-SE25 | 04-08-2025 | Ascend Laboratories SpA | $2.027.855 |
| 1058071-2482-SE25 | 21-07-2025 | Novofarma Service S.A. | $862.560 |
Fuente original:ficha mercadopublico.cl
